Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE2288.058.55 (+0.38 %)
PREV CLOSE () 2279.50
OPEN PRICE () 2300.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14559
TODAY'S LOW / HIGH ()2269.65 2300.00
52 WK LOW / HIGH ()1838.65 2492
NSE2287.205.4 (+0.24 %)
PREV CLOSE() 2281.80
OPEN PRICE () 2294.00
BID PRICE (QTY) 2287.20 (1449)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 773725
TODAY'S LOW / HIGH() 2269.80 2294.00
52 WK LOW / HIGH ()1836.8 2494
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1983

Management Info :

Manju D Gupta - Chairman Nilesh Gupta - Managing Director

Registered Office :

Address : Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone : 022 66402323

Email : info@lupin.com

Website : www.lupin.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
22May Lupin gets China’s National Medical Pr
Lupin has received approval from China’s National Medical Products Admin..
22May Lupin informs about press release
Lupin has informed that it enclosed a Press Release titled ‘Lupin Receiv..
19May Lupin makes debut in Dow Jones Best-in
Lupin has been featured for the first time in the Dow Jones Best-in-Clas..
19May Lupin gets USFDA tentative approval fo
Lupin has received tentative approval from the United States Food and Dr..
19May Lupin moves up on getting USFDA tentat
Lupin is currently trading at Rs. 2272.00, up by 19.00 points or 0.84% f..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit21636.963665.6
Gross Profit 26023.5 76942.5
Operating Profit 23704.481163.3
Net Sales 52346195126.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 8795.40 (2.22%)
M.Cap ( in Cr)
21988.50
Procter&Gamble Healt (BSE)
 5721.40 (2.88%)
M.Cap ( in Cr)
9497.17
Mercury Laboratories (BSE)
 888.25 (19.99%)
M.Cap ( in Cr)
106.59
Neuland Laboratories (BSE)
 16742.45 (0.65%)
M.Cap ( in Cr)
21480.38
Kwality Pharma (BSE)
 2230.55 (4.47%)
M.Cap ( in Cr)
2314.46
Shareholding Pattern
PROMOTERS 46.86%
MUTUAL FUNDS/UTI 16.93%
FI/BANKS/INSURANCE 6.12%
NON-INSTITUTION 6.11%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX76488.961073.61 (1.42%)
NIFTY24031.70312.40 (1.32%)
Dow Jones 50579.70294.04 (0.58%)
Nasdaq 26343.9750.87 (0.19%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI